Royalty Pharma PLC
F:RPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royalty Pharma PLC
F:RPD
|
US |
|
Coor Service Management Holding AB
F:COE
|
SE |
|
Amplify Energy Corp
F:2OQ
|
US |
|
5
|
5E Advanced Materials Inc
ASX:5EA
|
US |
Wall St Price Targets
RPD Price Targets Summary
Royalty Pharma PLC
According to Wall Street analysts, the average 1-year price target for RPD is 31.65 EUR with a low forecast of 25.19 EUR and a high forecast of 37.57 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPD's stock price target?
Price Target
31.65
EUR
According to Wall Street analysts, the average 1-year price target for RPD is 31.65 EUR with a low forecast of 25.19 EUR and a high forecast of 37.57 EUR.
What is the Revenue forecast for Royalty Pharma PLC?
Projected CAGR
18%
Over the last 7 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 18%.
What is the Operating Income forecast for Royalty Pharma PLC?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Royalty Pharma PLC?
Projected CAGR
37%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 37%.
What is the Net Income forecast for Royalty Pharma PLC?
Projected CAGR
63%
Over the last 7 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 3 years is 63%.
